Evidence map›Paper›PMID 37218750›Full record

ArticleBiotech (Basel (Switzerland))2023

A Bacterial Myeloperoxidase with Antimicrobial Properties.

Claire Céré, Brigitte Delord, Parfait Kenfack Ymbe, Léa Vimbert, Jean-Paul Chapel, Claire Stines-Chaumeil

Open access · goldAbstract read
In one paragraph

Article in Biotech (Basel (Switzerland)), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Claire CéréCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.
Brigitte DelordCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.
Parfait Kenfack YmbeCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.
Léa VimbertCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.
Jean-Paul ChapelCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.ORCID 0000-0002-1988-1288
Claire Stines-ChaumeilCNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, F-33600 Pessac, France.ORCID 0000-0002-1863-6117
Centre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche N°ANR-18-CE19-0028-01
6 · The paper itself

Abstract

The four mammalian peroxidases (myeloperoxidase, eosinophilperoxidase, lactoperoxidase, and thyroid peroxidase) are widely studied in the literature. They catalyze the formation of antimicrobial compounds and participate in innate immunity. Owing to their properties, they are used in many biomedical, biotechnological, and agro-food applications. We decided to look for an enzyme that is easiest to produce and much more stable at 37 °C than mammalian peroxidases. To address this question, a peroxidase from

Indexed as

hemehypohalide and pseudo-hypohalide productsmicrobicidymyeloperoxidase

Identifiers

PMID37218750
PMCPMC10204396
OpenAlexW4372338247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.